Mirum Pharmaceuticals (MIRM) Research & Development (2019 - 2026)
Mirum Pharmaceuticals (MIRM) reported Research & Development of $107.93 million for Q3 2026, up 151.2% from $42.96 million a year earlier and up 19.2% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Research & Development (2019 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Mirum Pharmaceuticals' Research & Development came in at $352.48 million, up 102.5% year-over-year; for FY2025, it came in at $186.18 million, up 32.4% from FY2024.
- Research & Development has a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
- By year, Research & Development came in at $140.63 million in FY2024 (+37.1%), $102.61 million in FY2023 (-4.0%), $106.84 million in FY2022 (-18.7%) and $131.43 million in FY2021 (+61.1%).
- The Q3 2026 figure ranks as the highest quarterly Research & Development in data going back to Q1 2019.
- Year over year, Research & Development has now increased in each of the last 11 quarters, with growth averaging 70.0% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2026 (growth of 151.2%); the low point was Q1 2022 (a decline of 36.8%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $90.53 million (Q2 2026), $97.91 million (Q1 2026) and $56.11 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Mirum Pharmaceuticals | 6.06 Bn | 4.48 Bn | 150.55 Mn | 107.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 107.93 Mn |
| Jun 30, 2026 | 90.53 Mn |
| Mar 31, 2026 | 97.91 Mn |
| Dec 31, 2025 | 51.11 Mn |
| Sep 30, 2025 | 42.96 Mn |
| Jun 30, 2025 | 46.07 Mn |
| Mar 31, 2025 | 41.04 Mn |
| Dec 31, 2024 | 44.03 Mn |
| Sep 30, 2024 | 31.71 Mn |
| Jun 30, 2024 | 32.67 Mn |
| Mar 31, 2024 | 32.22 Mn |
| Dec 31, 2023 | 30.94 Mn |
| Sep 30, 2023 | 26.12 Mn |
| Jun 30, 2023 | 22.01 Mn |
| Mar 31, 2023 | 23.55 Mn |
| Dec 31, 2022 | 31.11 Mn |
| Sep 30, 2022 | 26.22 Mn |
| Jun 30, 2022 | 25.43 Mn |
| Mar 31, 2022 | 24.09 Mn |
| Dec 31, 2021 | 27.78 Mn |
API Access
Mirum Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();